Candesartan and epigallocatechin‐3‐gallate ameliorate gentamicin‐induced renal damage in rats through p38‐MAPK and NF‐κB pathways

HI Ahmed, EA Mohamed - Journal of biochemical and …, 2019 - Wiley Online Library
This study pointed to estimate the possible protective impacts of candesartan and/or
epigallocatechin‐3‐gallate (EGCG) against gentamicin‐induced nephrotoxicity. The current …
被引用次数：35 相关文章

Candesartan and epigallocatechin-3-gallate ameliorate gentamicin-induced renal damage in rats through p38-MAPK and NF-κB pathways.

HI Ahmed, EA Mohamed - Journal of Biochemical and Molecular …, 2018 - europepmc.org
This study pointed to estimate the possible protective impacts of candesartan and/or
epigallocatechin-3-gallate (EGCG) against gentamicin-induced nephrotoxicity. The current …

Candesartan and epigallocatechin-3-gallate ameliorate gentamicin-induced renal damage in rats through p38-MAPK and NF-κB pathways

HI Ahmed, EA Mohamed - Journal of biochemical and …, 2019 - pubmed.ncbi.nlm.nih.gov
This study pointed to estimate the possible protective impacts of candesartan and/or
epigallocatechin-3-gallate (EGCG) against gentamicin-induced nephrotoxicity. The current …

Candesartan and epigallocatechin‐3‐gallate ameliorate gentamicin‐induced renal damage in rats through p38‐MAPK and NF‐κB pathways.

HI Ahmed, EA Mohamed - Journal of Biochemical & …, 2019 - search.ebscohost.com
This study pointed to estimate the possible protective impacts of candesartan and/or
epigallocatechin‐3‐gallate (EGCG) against gentamicin‐induced nephrotoxicity. The current …